Azathioprine Withdrawn Phase 2 Trials for Systemic Lupus Erythematosus (SLE) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00230035Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)